Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia.
Dong, L.M., Parkin, S., Trakhanov, S.D., Rupp, B., Simmons, T., Arnold, K.S., Newhouse, Y.M., Innerarity, T.L., Weisgraber, K.H.(1996) Nat Struct Biol 3: 718-722
- PubMed: 8756331 
- DOI: 10.1038/nsb0896-718
- Primary Citation of Related Structures:  
1NFN, 1NFO - PubMed Abstract: 
The defective binding of apolipoprotein (apo) E2 to lipoprotein receptors, an underlying cause of type III hyperlipoproteinemia, results from replacement of Arg 158 with Cys, disrupting the naturally occurring salt bridge between Asp 154 and Arg 158. A new bond between Asp 154 and Arg 150 is formed, shifting Arg 150 out of the receptor binding region ...